These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26795264)

  • 1. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps.
    Sari K; Gencer ZK; Ede H; Gocmen AY; Kantekin Y
    Auris Nasus Larynx; 2016 Oct; 43(5):529-36. PubMed ID: 26795264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
    Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
    ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
    Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15, ischemia modified albumin and pregnancy-associated plasma protein A in patients with coronary artery disease.
    Fan LY; Jin ZG; Zong M; Wang QZ; Ju Y; Sun LS; Gu YY; Yu P; Zhang DF; Liu ZM
    Clin Lab; 2014; 60(6):973-82. PubMed ID: 25016703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cardiovascular disease risk in women with surgically induced menopause.
    Sari N; Engin-Üstün Y; Kiyak Çağlayan E; Göçmen AY; Polat MF
    Gynecol Endocrinol; 2016 Jun; 32(6):498-501. PubMed ID: 26800355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.
    Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
    Zhu ZD; Sun T
    Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum.
    Krintus M; Braga F; Kozinski M; Borille S; Kubica J; Sypniewska G; Panteghini M
    Clin Chem Lab Med; 2019 Jun; 57(7):1035-1043. PubMed ID: 30471215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor-15 and major cardiac events.
    Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
    Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
    Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
    J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction.
    Minamisawa M; Motoki H; Izawa A; Kashima Y; Hioki H; Abe N; Miura T; Ebisawa S; Miyashita Y; Koyama J; Ikeda U
    Int Heart J; 2016; 57(1):11-7. PubMed ID: 26742699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress.
    Kazanis K; Dalamaga M; Kassi E; Nounopoulos C; Manolis AS; Merantzi G; Jullien G; Dionyssiou-Asteriou A
    Maturitas; 2011 Oct; 70(2):182-7. PubMed ID: 21839592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease.
    Montagnana M; Lippi G; Fava C; Minuz P; Santonastaso CL; Arosio E; Guidi GC
    Clin Chem Lab Med; 2006; 44(2):207-12. PubMed ID: 16475909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
    Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
    Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of serum growth differentiation factor-15 level in patients with obstructive sleep apnea.
    Sari K; Ede H; Kapusuz Gencer Z; Ozkiris M; Gocmen AY; Intepe YS
    Biomed Res Int; 2015; 2015():807683. PubMed ID: 26075263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise on serum ischemia-modified albumin, brain natriuretic peptide and copeptin levels in boxers and kick boxers.
    Memmedov H; Bakan E; Ozturk N; Baygutalp NK; Kaynar O; Gul MA; Kaya A; Kıyıcı F; Yazıcı AG
    Pan Afr Med J; 2022; 41():98. PubMed ID: 35465367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor 15 in different stages of heart failure: potential screening implications.
    Wang F; Guo Y; Yu H; Zheng L; Mi L; Gao W
    Biomarkers; 2010 Dec; 15(8):671-6. PubMed ID: 20860541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.